These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8996861)

  • 41. Evaluation of diethylenetriaminepentaacetic acid-manganese(II) complexes modified by narrow molecular weight distribution of chitosan oligosaccharides as potential magnetic resonance imaging contrast agents.
    Huang Y; Zhang X; Zhang Q; Dai X; Wu J
    Magn Reson Imaging; 2011 May; 29(4):554-60. PubMed ID: 21277723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
    Li J; Wu C; Hou P; Zhang M; Xu K
    Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manganese-free chow, a refined non-invasive solution to reduce gastrointestinal signal for T
    Kersemans V; Wallington S; Allen PD; Gilchrist S; Kinchesh P; Browning R; Vallis KA; Schilling K; Holdship P; Stork LA; Smart S
    Lab Anim; 2020 Aug; 54(4):353-364. PubMed ID: 31526094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Labelling of manganese-based magnetic resonance imaging (MRI) contrast agents with the positron emitter 51Mn, as exemplified by manganese-tetraphenyl-porphin-sulfonate (MnTPPS4).
    Klein AT; Rösch F; Coenen HH; Qaim SM
    Appl Radiat Isot; 2005 May; 62(5):711-20. PubMed ID: 15763477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.
    Kim SM; Im GH; Lee DG; Lee JH; Lee WJ; Lee IS
    Biomaterials; 2013 Nov; 34(35):8941-8. PubMed ID: 23973173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melanin-manganese nanoparticles with ultrahigh efficient clearance in vivo for tumor-targeting T
    Xu W; Sun J; Li L; Peng X; Zhang R; Wang B
    Biomater Sci; 2017 Dec; 6(1):207-215. PubMed ID: 29210372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual T
    Suárez-García S; Arias-Ramos N; Frias C; Candiota AP; Arús C; Lorenzo J; Ruiz-Molina D; Novio F
    ACS Appl Mater Interfaces; 2018 Nov; 10(45):38819-38832. PubMed ID: 30351897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents.
    Estelrich J; Sánchez-Martín MJ; Busquets MA
    Int J Nanomedicine; 2015; 10():1727-41. PubMed ID: 25834422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spin-lock MRI with amplitude- and phase-modulated adiabatic waveforms: an MR simulation study.
    Taheri S; Sood R
    Magn Reson Imaging; 2006 Jan; 24(1):51-9. PubMed ID: 16410178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An aqueous method for the controlled manganese (Mn(2+)) substitution in superparamagnetic iron oxide nanoparticles for contrast enhancement in MRI.
    Ereath Beeran A; Nazeer SS; Fernandez FB; Muvvala KS; Wunderlich W; Anil S; Vellappally S; Ramachandra Rao MS; John A; Jayasree RS; Varma PR
    Phys Chem Chem Phys; 2015 Feb; 17(6):4609-19. PubMed ID: 25586703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A mononuclear manganese(II) complex demonstrates a strategy to simultaneously image and treat oxidative stress.
    Yu M; Ambrose SL; Whaley ZL; Fan S; Gorden JD; Beyers RJ; Schwartz DD; Goldsmith CR
    J Am Chem Soc; 2014 Sep; 136(37):12836-9. PubMed ID: 25187295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear magnetic resonance tissue analysis of acute renal artery and renal vein occlusion: the effect of a paramagnetic contrast agent.
    Strich G; Slutsky RA
    J Urol; 1984 Dec; 132(6):1216-9. PubMed ID: 6502826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solvent proton magnetic relaxation dispersion in solutions of concanavalin A.
    Koenig SH; Brown RD; Brewer CF
    Proc Natl Acad Sci U S A; 1973 Feb; 70(2):475-9. PubMed ID: 4346891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A highly stable l-alanine-based mono(aquated) Mn(ii) complex as a T
    Khannam M; Weyhermüller T; Goswami U; Mukherjee C
    Dalton Trans; 2017 Aug; 46(31):10426-10432. PubMed ID: 28745775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mn-bicine: a low affinity chelate for manganese ion enhanced MRI.
    Seo Y; Satoh K; Watanabe K; Morita H; Takamata A; Ogino T; Murakami M
    Magn Reson Med; 2011 Apr; 65(4):1005-12. PubMed ID: 21413064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Graphene oxide/manganese ferrite nanohybrids for magnetic resonance imaging, photothermal therapy and drug delivery.
    Yang Y; Shi H; Wang Y; Shi B; Guo L; Wu D; Yang S; Wu H
    J Biomater Appl; 2016 Jan; 30(6):810-22. PubMed ID: 26296777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide.
    Yu M; Beyers RJ; Gorden JD; Cross JN; Goldsmith CR
    Inorg Chem; 2012 Sep; 51(17):9153-5. PubMed ID: 22889331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative activation-induced manganese-enhanced MRI reveals severity of Parkinson's disease in mice.
    Kikuta S; Nakamura Y; Yamamura Y; Tamura A; Homma N; Yanagawa Y; Tamura H; Kasahara J; Osanai M
    Sci Rep; 2015 Aug; 5():12800. PubMed ID: 26255701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.